About Actuate Therapeutics

Actuate Therapeutics provides advanced research for the treatment of high-impact cancers and neurodegenerative diseases. It is a private biopharmaceutical company focused on the development of compounds for use in the treatment of cancer and inflammatory diseases leading to fibrosis and neurodegeneration. The company aims to discover, develop, and commercialize new agents that target GSK-3β. Actuate Therapeutics is currently advancing its lead molecule, 9-ING-41, toward the clinic in 2017. Ongo

Company Highlights
Year Founded

2015

icon-altEmployees

9

Location (HQ)

USA

Since Last Funding

1 year 10 months

Monthly Website Visitors

2.4K

icon-altTotal Investment Amt

$65M

Last Funding Round

Series Unknown

icon-altYoY Headcount Growth

12.35%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Similar Companies

Medical

Biotechnology

Pharmaceutical Manufacturing

Pharmaceuticals

Pharmaceutical